BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 32831998)

  • 21. Ellagic acid attenuates streptozocin induced diabetic nephropathy via the regulation of oxidative stress and inflammatory signaling.
    Zhou B; Li Q; Wang J; Chen P; Jiang S
    Food Chem Toxicol; 2019 Jan; 123():16-27. PubMed ID: 30342113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6.
    Li H; Wang Y; Zhou Z; Tian F; Yang H; Yan J
    Ren Fail; 2019 Nov; 41(1):899-906. PubMed ID: 31552773
    [No Abstract]   [Full Text] [Related]  

  • 23. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways.
    Zhu X; Shi J; Li H
    Biomed Pharmacother; 2018 Oct; 106():976-982. PubMed ID: 30119269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.
    Kim MH; Kang SG; Park JH; Yanagisawa M; Kim CH
    Gastroenterology; 2013 Aug; 145(2):396-406.e1-10. PubMed ID: 23665276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
    Li F; Chen Y; Li Y; Huang M; Zhao W
    Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome.
    Samra YA; Said HS; Elsherbiny NM; Liou GI; El-Shishtawy MM; Eissa LA
    Life Sci; 2016 Jul; 157():187-199. PubMed ID: 27266851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.
    Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z
    Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Akebia Saponin D ameliorated kidney injury and exerted anti-inflammatory and anti-apoptotic effects in diabetic nephropathy by activation of NRF2/HO-1 and inhibition of NF-KB pathway.
    Lu C; Fan G; Wang D
    Int Immunopharmacol; 2020 Jul; 84():106467. PubMed ID: 32344355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nobiletin suppresses high-glucose-induced inflammation and ECM accumulation in human mesangial cells through STAT3/NF-κB pathway.
    Liu Z; Han Y; Zhao F; Zhao Z; Tian J; Jia K
    J Cell Biochem; 2019 Mar; 120(3):3467-3473. PubMed ID: 30499124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells.
    Zhang S; Xu L; Liang R; Yang C; Wang P
    J Physiol Biochem; 2020 Aug; 76(3):407-416. PubMed ID: 32500512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated network pharmacology and pharmacological investigations to discover the active compounds of Toona sinensis pericarps against diabetic nephropathy.
    Li H; Wang R; Chen Y; Zhao M; Lan S; Zhao C; Li X; Li W
    J Ethnopharmacol; 2024 Jun; 333():118441. PubMed ID: 38851471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effect of short-chain fatty acids against oxidative stress-induced SH-SY5Y injury via GPR43-dependent pathway.
    Saikachain N; Sungkaworn T; Muanprasat C; Asavapanumas N
    J Neurochem; 2023 Jul; 166(2):201-214. PubMed ID: 37070532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium butyrate protects against lipopolysaccharide-induced liver injury partially via the GPR43/ β-arrestin-2/NF-κB network.
    Luo QJ; Sun MX; Guo YW; Tan SW; Wu XY; Abassa KK; Lin L; Liu HL; Jiang J; Wei XQ
    Gastroenterol Rep (Oxf); 2021 Apr; 9(2):154-165. PubMed ID: 34026223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy.
    Opazo-Ríos L; Plaza A; Sánchez Matus Y; Bernal S; Lopez-Sanz L; Jimenez-Castilla L; Carpio D; Droguett A; Mezzano S; Egido J; Gomez-Guerrero C
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consumption of barley flour increases gut fermentation and improves glucose intolerance
    Mio K; Iida-Tanaka N; Yamanaka C; Kimura I; Aoe S
    Food Funct; 2022 Oct; 13(21):10970-10980. PubMed ID: 36254783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.